# Phase I Clinical Study of YK1101 Injection for the Treatment of Advanced Solid Tumors

> **NCT07139067** · PHASE1 · RECRUITING · sponsor: **Peking University** · enrollment: 10 (estimated)

## Conditions studied

- Advanced Solid Tumor Cancer

## Interventions

- **BIOLOGICAL:** YK1101 cells

## Key facts

- **NCT ID:** NCT07139067
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-27
- **Primary completion:** 2026-07-01
- **Final completion:** 2028-07-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07139067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07139067, "Phase I Clinical Study of YK1101 Injection for the Treatment of Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07139067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*